IYH iShares U.S. Healthcare ETF
Quote as of Oct 09, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 70.92 | Day Range | 70.69 – 72.23 |
| 52-Week Range | 59.47 – 74.59 | Volume | 931.13K |
| Avg Volume | 789.36K | AUM | $3.99B (Oct 10, 2026) |
| Expense Ratio | 0.37% | Yield (TTM) | 1.11% |
| NAV | 71.01 | Premium/Discount | +1.59% indicative |
| Inception | Jun 12, 2000 | Holdings | 100 |
| Issuer | iShares | Exchange | AMEX |
| Category | Healthcare | Index Tracked | Not stated in source data |
| CUSIP | 464287762 | ISIN | US4642877629 |
| Management | Not stated in source data | ||
About this ETF
The iShares U.S. Healthcare ETF is designed to mirror the investment performance of a benchmark index that consists of stocks from American companies within the healthcare industry.
Description from the fund data provider · profile as of Oct 10, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +2.43% | +6.26% | +16.75% | +10.81% | +18.48% | +9.53% | +5.56% | +9.42% | +8.89% |
| Total return | +2.43% | +6.26% | +17.03% | +11.43% | +19.60% | +10.75% | +6.76% | +10.79% | +10.37% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Oct 09, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.37% | Annual cost of a $10,000 investment | $37.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Oct 10, 2026 · portfolio reporting date from the data provider; holdings are not live positions. 103 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ELI LILLY | LLY | 14.83% | 520.66K | $609.0M |
| 2 | JOHNSON & JOHNSON | JNJ | 9.81% | 1.57M | $403.0M |
| 3 | ABBVIE | ABBV | 7.66% | 1.15M | $314.5M |
| 4 | MERCK & CO INC | MRK | 5.59% | 1.61M | $229.7M |
| 5 | UNITEDHEALTH GROUP | UNH | 5.32% | 588.89K | $218.4M |
| 6 | THERMO FISHER SCIENTIFIC INC | TMO | 3.85% | 242.42K | $158.1M |
| 7 | AMGEN INC | AMGN | 3.49% | 351.99K | $143.4M |
| 8 | GILEAD SCIENCES | GILD | 2.90% | 810.17K | $119.2M |
| 9 | ABBOTT LABORATORIES | ABT | 2.71% | 1.13M | $111.3M |
| 10 | PFIZER | PFE | 2.52% | 3.71M | $103.3M |
| 11 | INTUITIVE SURGICAL | ISRG | 2.33% | 229.91K | $95.5M |
| 12 | DANAHER | DHR | 2.18% | 412.10K | $89.6M |
| 13 | VERTEX PHARMACEUTICALS | VRTX | 2.03% | 165.78K | $83.4M |
| 14 | BRISTOL MYERS SQUIBB | BMY | 1.93% | 1.33M | $79.3M |
| 15 | MEDTRONIC PLC | MDT | 1.79% | 836.43K | $73.4M |
| 16 | STRYKER | SYK | 1.52% | 225.54K | $62.5M |
| 17 | ELEVANCE HEALTH INC | ELV | 1.38% | 141.55K | $56.8M |
| 18 | REGENERON PHARMACEUTICALS | REGN | 1.17% | 64.72K | $47.9M |
| 19 | CIGNA | CI | 1.17% | 170.27K | $47.9M |
| 20 | MODERNA | MRNA | 1.14% | 237.34K | $46.8M |
| 21 | HCA HEALTHCARE | HCA | 1.03% | 95.05K | $42.3M |
| 22 | BOSTON SCIENTIFIC CORP | BSX | 0.99% | 966.95K | $40.7M |
| 23 | NATERA | NTRA | 0.85% | 89.09K | $34.8M |
| 24 | BECTON DICKINSON | BDX | 0.80% | 179.41K | $32.8M |
| 25 | EDWARDS LIFESCIENCES | EW | 0.76% | 371.80K | $31.3M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 1.11% | Paid (last 12 months) | $0.7987 |
| Frequency | Quarterly | SEC yield | Not provided by our data source; see the issuer page |
| Last ex-date | Sep 15, 2026 | Last payment | $0.1908 (Sep 18, 2026) |
| Growth 1Y | +10.48% | Growth 3Y / 5Y (ann.) | -37.68% / -22.17% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Sep 15, 2026 | Sep 15, 2026 | Sep 18, 2026 | $0.1908 |
| Jun 15, 2026 | Jun 15, 2026 | Jun 18, 2026 | $0.1634 |
| Mar 17, 2026 | Mar 17, 2026 | Mar 20, 2026 | $0.1948 |
| Dec 16, 2025 | Dec 16, 2025 | Dec 19, 2025 | $0.2497 |
| Sep 16, 2025 | Sep 16, 2025 | Sep 19, 2025 | $0.1928 |
| Jun 16, 2025 | Jun 16, 2025 | Jun 20, 2025 | $0.1682 |
| Mar 18, 2025 | Mar 18, 2025 | Mar 21, 2025 | $0.1624 |
| Dec 17, 2024 | Dec 17, 2024 | Dec 20, 2024 | $0.1995 |
| Sep 25, 2024 | Sep 25, 2024 | Sep 30, 2024 | $0.2342 |
| Jun 11, 2024 | Jun 11, 2024 | Jun 17, 2024 | $0.1258 |
| Mar 21, 2024 | Mar 22, 2024 | Mar 27, 2024 | $0.1666 |
| Dec 20, 2023 | Dec 21, 2023 | Dec 27, 2023 | $0.8888 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 15.79% / 15.00% | Sharpe 1Y / 3Y | 1.22 / 0.545 |
| Max drawdown 1Y / 3Y | -10.65% / -17.91% | Sortino 1Y | 2.02 |
| Beta vs S&P 500 (3Y) | 0.477 | Correlation vs S&P 500 (1Y) | 0.25 |
| Downside deviation 1Y | 9.54% | Risk-free rate used | 4.05% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Oct 11, 2026. Formulas →
Liquidity
| Volume today | 931.13K | Average volume | 789.36K |
| AUM | $3.99B | Premium/Discount | +1.59% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | -$11.8M | -0.29% | $4.01B → $3.99B |
| 1 Month | $270.7M | +7.50% | $3.61B → $3.99B |
| 1 Week | -$145.5M | -3.60% | $4.04B → $3.99B |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing.
Latest News for IYH
No articles mention this fund directly in the last 7 days; showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.